CellSource Co.,Ltd. (4880.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.3x

Market Cap

JPY 6.76B

MomentumView details →

1D Return

−0.58%

YTD Return

−13.28%

RSI (14)

52.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.3x

Market Cap

JPY 6.76B

RSI (14)

52.6

MomentumView details →

1D Return

−0.58%

YTD Return

−13.28%

ProfitabilityView details →

Gross Margin

56.08%

Net Margin

2.36%

EBITDA Margin

9.79%

ROE (TTM)

1.48%

ROA (TTM)

1.28%

Asset Turnover

0.53x

GrowthView details →

Revenue YoY

−7.67%

EPS YoY

+79.30%

FCF YoY

—

Revenue CAGR 3Y

−4.59%

EPS CAGR 3Y

−78.53%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

13.95x

Quick Ratio

13.75x

Div Yield

1.47%

Div Rate

JPY 5.00

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

3.72B

Net Income (TTM)

88.00M

Op. CF (TTM)

—

Next earningsSep 8, 2026 →

Latest newsMore news →

CellSource and Solaris Bio jointly developed freeze-drying technology for extracellular vesicles including exosomes.4d ago

Similar companies

Solasia Pharma K.K.4597.T PRISM BioLab Co.,LTD206A.T Noile-Immune Biotech Inc.4893.T J-Pharma Co.,Ltd.520A.T Nano Holdings,Inc.4571.T Tsubota Laboratory Incorporated4890.T Find similar companies →

Latest newsMore news →

CellSource and Solaris Bio jointly developed freeze-drying technology for extracellular vesicles including exosomes.4d ago